The athlete and high altitude
| Autor: | Kevin deWeber, Richard Derby |
|---|---|
| Rok vydání: | 2010 |
| Předmět: |
medicine.medical_specialty
biology business.industry Athletes Incidence (epidemiology) Public Health Environmental and Occupational Health General Medicine Effects of high altitude on humans Altitude Sickness Athletic Performance biology.organism_classification medicine.disease Pulmonary edema Cerebral edema Altitude Oxygen Consumption Risk Factors Emergency medicine Medicine Humans Orthopedics and Sports Medicine Salmeterol business Acetazolamide medicine.drug |
| Zdroj: | Current sports medicine reports. 9(2) |
| ISSN: | 1537-8918 |
| Popis: | Expanding athlete participation in high-altitude environments highlights the importance for a sports physician to have a good understanding of the high-altitude illness (HAI) syndromes: acute mountain sickness (AMS), high-altitude cerebral edema (HACE), and high-altitude pulmonary edema (HAPE). All may occur in the setting of acute altitude exposure higher than 2500 m; incidence and severity increases as altitudes or ascent rates increase. Once HAI is recognized, proven therapies should be instituted to alleviate symptoms and avert the possibility of critical illness. Allowing for acclimatization is the best strategy for preventing HAI. Acetazolamide and dexamethasone are additional preventive measures for AMS/HACE; nifedipine, salmeterol, and phosphodiesterase inhibitors are useful in preventing HAPE. Along with the immediate hazards of HAI with altitude exposure, the sport physician also should be familiar with altitude/hypoxic training practices used by athletes to enhance fitness and performance. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|